Biotechnology firms operate in a highly innovative and capital-intensive environment, characterized by high levels of R&D, long product development periods, significant regulations, and high levels of uncertainty. These firms rely heavily on intangible assets, such as intellectual capital and...

Purpose The purpose of this study is to identify papers that have produced the most significant impact on research on strategic alliances in the biotechnology industry. The authors attempt to illustrate the thematic evolution of its intellectual structure through 616 papers published between...

This Communication aims to unlock the full benefits of biotechnologies and biomanufacturing, which are crucial for the competitiveness and modernisation of EU industry and offer high growth and productivity potential.

The biopharmaceutical sector is of considerable interest during the COVID-19 pandemic. This study aims to investigate the biopharmaceutical sector using the Shenwan Industry Classification and provides insights into investment strategies. We combine factor and cluster analyses to reduce data...

The study explores entrepreneurial ecosystems, which emphasize the impact of regional context on entrepreneurship, with a particular focus on the health sector. Given its innovation and knowledge intensity, coupled with industry-specific challenges, the health sector serves as an ideal case for...

The oil industry is responsible for production of many products in common use, such as plastic and fuel, which are used in various activities in modern society. However, the exploitation of these hydrocarbons has been considered aggressive to the environment and their reservoirs are not...

Objective: The article aims to verify the development of innovation cooperation in the biopharmaceutical (biotech, pharma) industry in Central and Eastern Europe (CEE) taking into account the directions of innovation cooperation. I will try to verify the importance of location in innovation...

The link between entrepreneur's network centrality and innovation performance has been broadly studied in knowledge-intensive industries such as biotechnology. However, little research has been focused on the social mechanisms that allow innovators to reach such a central position. We contribute...

Apart from the basic statutory definition in section 65 of the Intellectual Property Act of Sri Lanka, there do not appear to be any detailed statutory guidelines or judicial decisions to provide any framework for the assessment of inventive step in Sri Lanka. The current statutory definition is...

Climate change has induced an ecological crisis necessitating reconsideration of how the law should manage human interactions with ecological systems. In most Western legal regimes, conservation policy has principally sought to advance historical or natural preservation or sustained yield...

Through a longitudinal study of the product development portfolios of 457 US-based firms in the biotechnology industry, we investigate how prolific inventors shape a firm’s innovative direction following product development failure. Contrary to received wisdom, we argue and demonstrate that an...

The continued impact of COVID-19 in the biotechnology sector is distinct from other industries, putting an additional strain on biotech employees. Like frontline workers, employees in biotechnology encounter circumstances where their performance is measured by life and death outcomes. Research...

Corporate financial managers of biotech firms need long‐term financing to reach key milestones, and that requires a long‐ term capital structure. They must balance a mix of investors with different objectives and different investment horizons that includes traditional venture capitalists and...

Research on how managers control R&D activities has tended to focus on the performance measurement systems used to exploit existing knowledge and capabilities. This focus has been at the expense of how broader forms of management control could be used to enable R&D contextual ambidexterity, the...

"Providing a comprehensive account of the latest research and thinking on the bioeconomy, Davide Viaggi brings together expert authors to reflect on the economics of using renewable biological resources to produce bio-based materials, food, energy and more, through a wide set of technological...

Due to the COVID-19 pandemic, interest in COVID-19 vaccines and treatments has grown. In addition, awareness of the importance of healthcare and disease prevention has risen, thus demand for related goods has also increased. There are movements to preempt emerging industries, such as...

With the creation of start-up biotech businesses being a very risky pursuit, with capital intensive projects, long product development lead times and regulatory hurdles to overcome, support for such businesses is essential. Business incubators have long been a method of improving start-up...

Whether it is a government research institution, a public-private partnership, or a private enterprise, the South African biotechnology industry requires funding for the biotechnology industry. Our goal with this research is to look into the role of venture capital (VC) in financing biotech...

While the use of artificial intelligence (AI) systems promises to bring significant economic and social benefits, it is also coupled with ethical, legal, and technical challenges. Business leaders thus face the question of how to best reap the benefits of automation whilst managing the...

Confronted with new global competitive environment, rising R&D costs, growing integration of different technologies, shorter life cycles, and increased pace of innovation, high-tech companies increasingly collaborate with external partners. Innovation networks became unconditional driver of...

The UK National Stem Cell Network (UKNSCN) provided the stem cell community with regular digests of both published patent applications and granted patents in the field of stem cells.This report provides an updated patent landscape overview for the period 1 November 2008 to 31 October 2011 with a...

Innovation most successfully occurs in regions around the world that allow inventors to operate in a public policy framework that rewards risk taking and investment. This is especially so for the biopharmaceutical industry. Because of the high risk, high cost, and long research timelines...

Biotechnology is a field which is utterly dependent on knowledge creation and management of novel innovations which are an outcome of contemporary knowledge. Knowledge management is a prime factor which determines the success or failure of a biotechnology company competing in the global...

Surfactants are amphiphilic compounds having both hydrophobic as well as hydrophilicmoieties. They tend to possess surface active characteristics by decreasing the surface tensionbetween the interfaces. Generally, a molecule of surfactant consists of a lipophilic group,usually a long-chain...

The paper at hand provides deep insights into the development of the German bioeconomy at the municipality level. The aim was to find out which determinants play a role in the location of bioeconomy patents at the municipality level and to analyze the respective stages of the bioeconomy in the...

Purpose - Drawing from legitimacy and institutional entrepreneurship theory, this study assesses the naming patterns of entrepreneurial firms in the US biotechnology industry. Design/methodology/approach - The authors use a mixed-methods design of content analysis and regression to analyze a...

The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered (or self-administered) to patients, intending to cure them, vaccinate them, or alleviate the symptoms. Pharmaceutical companies may deal in generic or...